Oppenheimer & Co. Inc. Sells 4,883 Shares of Aetna Inc (AET)

Oppenheimer & Co. Inc. lessened its holdings in Aetna Inc (NYSE:AET) by 73.7% during the 3rd quarter, HoldingsChannel reports. The firm owned 1,740 shares of the company’s stock after selling 4,883 shares during the quarter. Oppenheimer & Co. Inc.’s holdings in Aetna were worth $353,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Xact Kapitalforvaltning AB lifted its holdings in Aetna by 1.9% during the 2nd quarter. Xact Kapitalforvaltning AB now owns 70,818 shares of the company’s stock worth $12,995,000 after purchasing an additional 1,341 shares in the last quarter. Raymond James Trust N.A. increased its stake in Aetna by 6.7% in the 2nd quarter. Raymond James Trust N.A. now owns 6,513 shares of the company’s stock worth $1,195,000 after acquiring an additional 407 shares during the last quarter. Pennsylvania Trust Co bought a new position in Aetna in the 2nd quarter worth about $328,000. Atria Investments LLC increased its stake in Aetna by 18.5% in the 2nd quarter. Atria Investments LLC now owns 11,413 shares of the company’s stock worth $2,094,000 after acquiring an additional 1,779 shares during the last quarter. Finally, Central Bank & Trust Co. increased its stake in Aetna by 11.4% in the 2nd quarter. Central Bank & Trust Co. now owns 11,808 shares of the company’s stock worth $2,167,000 after acquiring an additional 1,211 shares during the last quarter. 83.46% of the stock is currently owned by institutional investors.

Shares of NYSE AET opened at $209.36 on Friday. The stock has a market capitalization of $68.37 billion, a price-to-earnings ratio of 21.23, a price-to-earnings-growth ratio of 1.77 and a beta of 0.71. The company has a debt-to-equity ratio of 0.42, a quick ratio of 0.79 and a current ratio of 0.79. Aetna Inc has a twelve month low of $166.88 and a twelve month high of $210.12.

Aetna (NYSE:AET) last announced its quarterly earnings data on Tuesday, October 30th. The company reported $2.96 EPS for the quarter, beating the consensus estimate of $2.83 by $0.13. The firm had revenue of $15.48 billion for the quarter, compared to analyst estimates of $15.40 billion. Aetna had a return on equity of 20.78% and a net margin of 5.99%. The company’s revenue was up 3.3% on a year-over-year basis. During the same period in the prior year, the company earned $2.45 EPS. Research analysts forecast that Aetna Inc will post 11.36 EPS for the current fiscal year.

The company also recently disclosed a quarterly dividend, which was paid on Thursday, November 1st. Stockholders of record on Wednesday, October 24th were given a dividend of $0.50 per share. The ex-dividend date of this dividend was Tuesday, October 23rd. This represents a $2.00 annualized dividend and a dividend yield of 0.96%. Aetna’s dividend payout ratio (DPR) is presently 20.28%.

A number of equities analysts have weighed in on the company. Citigroup upped their target price on Aetna from $202.00 to $206.00 and gave the stock a “neutral” rating in a research note on Wednesday, October 31st. Piper Jaffray Companies lowered Aetna from an “overweight” rating to a “neutral” rating and decreased their target price for the stock from $212.00 to $206.00 in a research note on Tuesday, October 30th. Credit Suisse Group decreased their target price on Aetna from $207.00 to $205.00 and set a “neutral” rating on the stock in a research note on Wednesday, October 31st. Cantor Fitzgerald restated a “hold” rating and issued a $204.00 target price on shares of Aetna in a research note on Tuesday, October 30th. Finally, Zacks Investment Research upgraded Aetna from a “sell” rating to a “hold” rating in a research note on Monday, August 6th. Eight investment analysts have rated the stock with a hold rating and four have issued a buy rating to the stock. The stock has an average rating of “Hold” and a consensus target price of $204.55.

TRADEMARK VIOLATION NOTICE: “Oppenheimer & Co. Inc. Sells 4,883 Shares of Aetna Inc (AET)” was originally posted by The Lincolnian Online and is the property of of The Lincolnian Online. If you are reading this report on another website, it was copied illegally and republished in violation of U.S. & international copyright & trademark legislation. The legal version of this report can be read at https://www.thelincolnianonline.com/2018/11/10/oppenheimer-co-inc-sells-4883-shares-of-aetna-inc-aet.html.

Aetna Company Profile

Aetna Inc operates as a health care benefits company in the United States. It operates through three segments: Health Care, Group Insurance, and Large Case Pensions. The Health Care segment offers medical, pharmacy benefit management service, dental, behavioral health, and vision plans on an insured and employer-funded basis.

Featured Article: Hedge Funds – How They Work For Investors

Want to see what other hedge funds are holding AET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aetna Inc (NYSE:AET).

Institutional Ownership by Quarter for Aetna (NYSE:AET)

Receive News & Ratings for Aetna Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aetna and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply